Agile Therapeutics: Q4 Earnings Insights
Agile Therapeutics (OTC:AGRX) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:05 AM. Here’s what…
Agile Therapeutics’s Earnings: A Preview
Agile Therapeutics (NASDAQ:AGRX) is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Here’s what investors…
5 Value Stocks In The Healthcare Sector
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the…
Agile Therapeutics Announces Extension Granted By Nasdaq Hearings Panel To Regain Compliance Until March 25, 2024; Sees FY23 Revenue $20M-$21M
Company Granted Extension by Nasdaq Hearings Panel to Regain Compliance with the Stockholders' Equity Continued Listing Requirement Until March 25, 2024 Net Revenue for Full Year 2023 Expected to be in the Range of
The Biden-Harris Administration Announces New Guidance To Enable Expanded Access To All FDA-Approved Contraceptives Without Cost
Implementation of the New Guidance Could Eliminate Financial Barriers for Contraceptive Products like Twirla® for 49 Million Women These Actions Follow Several Months of Activity by the Biden Administration to
A Look Into Healthcare Sector Value Stocks
The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices…
Overview Of Value Stocks In The Healthcare Sector
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers First Wave BioPharma (NASDAQ:FWBI) shares increased by 40.8% to $5.38 during Tuesday’s after-market session. The company’s market…
Agile Therapeutics Provides Update On Actions Being Taken To Strengthen The Affordable Care Act’s No-Cost Contraceptive Coverage Requirement
The Company Commends House Committee on Oversight and Accountability Ranking Member Jamie Raskin for New Report on Contraception Coverage Gaps New Report Follows Several Months of Activity by the Biden
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell
• Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.